Szela Mary T bought TLSI
February 23, 2026 · Form 4 insider transaction
Szela Mary T bought 30,487 shares of TriSalus Life Sciences, Inc. at $4.10 per share, a transaction worth $125.0K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
30,487
Price
$4.10
Total value
$125.0K
InsiderSzela Mary T
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateFebruary 23, 2026
Filing dateFebruary 23, 2026
Shares owned after773,289
OwnershipDirect
10b5-1 planNo
AmendedNo